06/05/2026
The Snowdome Foundation applauds a significant milestone for Australian patients living with multiple myeloma.
The announcement of government-funded access to the CAR T-cell therapy Carvykti, as a fourth-line treatment, is a major step forward in improving access to life-changing therapies.
This milestone is the result of tireless advocacy by patients, clinicians, and the broader community, who have worked to ensure these breakthrough treatments are within reach. Patients who were once waiting are now willing, ready - and able - to access this therapy.
While this is a significant step, it’s also a reminder of the importance of continuing this momentum. Access, equity, and earlier availability of innovative treatments like CAR T-cell therapy remain critical.
The Snowdome Foundation remains committed to advocating for equitable access to next-generation therapies for all Australians living with blood cancer.
Please watch the 7NEWS story:
🔗 https://www.youtube.com/watch?v=b2KQNhUAYw4
A tireless campaign by high-profile cancer patients has won a major victory. They've helped persuade the government to pay for groundbreaking myeloma treatme...